2 stories about Medi-Tate
מנכ"ל מדיטייט עידו קילמניק עם ונסה מלכה סמנכ"לית מדיטייט

Israel’s Medi-Tate acquired by Japanese powerhouse Olympus Corporation for $300 million

26.02.21|Meir Orbach
The Israeli manufacturer of non-surgical solutions for BPH had previously raised $37 million from private investors
אחות בית חולים סיעוד

Japan's Olympus Corporation Backs Israeli Medical Company Medi-Tate

Olympus agreed to invest $20 million in Medi-Tate, which develops medical devices to relieve symptoms of benign prostate enlargement